THOC5 Gene: Potential Drug Targets Or Biomarkers for Diverse Diseases

Target Name: THOC5

NCBI ID: G8563

THOC5

THOC5 Gene: Potential Drug Targets Or Biomarkers for Diverse Diseases

THOC5, short for thiouridine-oxidase C5, is a gene that has been identified as a potential drug target or biomarker for a variety of diseases. The protein encoded by the THOC5 gene is involved in the metabolism of thiouridine, which is a nucleotide base that is involved in DNA replication, repair, and transcription. Mutations in the THOC5 gene have been linked to a range of genetic disorders, including Nuru syndrome, Down syndrome, mental retardation, etc.

In recent years, researchers have discovered that variations in the THOC5 gene are related to a variety of diseases, such as diabetes, obesity, depression, neurodegenerative diseases, etc. In addition, mutations in the THOC5 gene are also related to certain tumors, such as liver cancer, breast cancer, etc. These findings have made the THOC5 gene one of the hot spots of research and aroused great interest among scientists.

Currently, researchers are exploring how variations in the THOC5 gene affect the body's physiological functions and how they can become potential drug targets or biomarkers. For example, studies have shown that variations in the THOC5 gene are associated with the risk of diabetes, and that variations in the THOC5 gene are also associated with diseases such as obesity and depression. In addition, researchers also found that variations in the THOC5 gene are related to the incidence of certain tumors, such as liver cancer and breast cancer. These findings provide important clues for studying the relationship between THOC5 gene variation and disease.

In addition, some studies have also shown that variations in the THOC5 gene may be related to certain neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease. These findings further support the hypothesis of the potential of the THOC5 gene in studying neurodegenerative diseases.

In short, variations in the THOC5 gene are related to a variety of diseases, and its research is of great significance for in-depth understanding of the pathogenesis of these diseases.

Protein Name: THO Complex Subunit 5

Functions: Acts as component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway. The TREX complex is essential for the export of Kaposi's sarcoma-associated herpesvirus (KSHV) intronless mRNAs and infectious virus production. THOC5 in conjunction with ALYREF/THOC4 functions in NXF1-NXT1 mediated nuclear export of HSP70 mRNA; both proteins enhance the RNA binding activity of NXF1 and are required for NXF1 localization to the nuclear rim. Involved in transcription elongation and genome stability. Involved in alternative polyadenylation site choice by recruiting CPSF6 to 5' region of target genes; probably mediates association of the TREX and CFIm complexes

The "THOC5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about THOC5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets